GI & Endoscopy

After a banner year for activity in 2019, COVID-19 disrupted private equity investment in the gastroenterology space. Yet activity has resumed as the year winds down to a close. 

The American College of Gastroenterology awarded University of Miami gastroenterologist Maria Abreu, MD, its Lifetime Disruptor award at ACG 2020, Oct. 23-28.

  Here are the five most-read stories about gastroenterology and endoscopy from Nov. 12-20:

  Here are four updates from GI companies and practices from the past week:

Exton, Pa.-based US Digestive Health partnered with West Chester (Pa.) GI Associates, the platform announced Nov. 17.

  Jacksonville, Fla.-based Digestive Disease Consultants is building a second ASC in the city, according to Abdi Abbassi, MD, a gastroenterologist with the practice.

While only 5.1 percent of COVID-19 patients admitted to intensive care units had severe gastrointestinal complications, those patients had a mortality rate of 55.6 percent, according to a pre-proof study published in Gastroenterology. 

Gastroenterologist and colorectal cancer screening pioneer David Ahlquist, MD, died Nov. 1 of amyotrophic lateral sclerosis. He was 69.

Oceanside, N.Y.-based Mount Sinai South Nassau broke ground on a 15,400-square-foot facility in Long Beach, N.Y., the health system announced Nov. 10.

The FDA approved Sebela Pharmaceuticals' colonoscopy preparation tablet Sutab, the company announced Nov. 10.